213 related articles for article (PubMed ID: 9923924)
21. Immunophenotypic heterogeneity in osteosarcomas.
Hasegawa T; Hirose T; Kudo E; Hizawa K; Usui M; Ishii S
Hum Pathol; 1991 Jun; 22(6):583-90. PubMed ID: 1864588
[TBL] [Abstract][Full Text] [Related]
22. Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts.
Folpe AL; Morris RJ; Weiss SW
Mod Pathol; 1999 Sep; 12(9):894-902. PubMed ID: 10496598
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of osteonectin in various types of osteosarcoma.
Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
25. Synovial sarcoma with extensive osteoid and bone formation.
Milchgrub S; Ghandur-Mnaymneh L; Dorfman HD; Albores-Saavedra J
Am J Surg Pathol; 1993 Apr; 17(4):357-63. PubMed ID: 7684201
[TBL] [Abstract][Full Text] [Related]
26. Soft-tissue osteosarcoma with prominent aneurysmatic bone cyst-like features: a case report.
Laforga JB; Jover A; MartÃnez P
Diagn Cytopathol; 2001 Mar; 24(3):209-14. PubMed ID: 11241907
[TBL] [Abstract][Full Text] [Related]
27. Properties of the stromal cell in giant cell tumor of bone.
Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
[TBL] [Abstract][Full Text] [Related]
28. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas.
Davis JL; Horvai AE
Histopathology; 2016 Jul; 69(1):84-90. PubMed ID: 26644288
[TBL] [Abstract][Full Text] [Related]
29. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
[TBL] [Abstract][Full Text] [Related]
31. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
32. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases.
Furusato E; Valenzuela IA; Fanburg-Smith JC; Auerbach A; Furusato B; Cameron JD; Rushing EJ
Hum Pathol; 2011 Jan; 42(1):120-8. PubMed ID: 21056898
[TBL] [Abstract][Full Text] [Related]
33. Immunohistological demonstration of osteonectin in normal bone tissue and in bone tumors.
Schulz A; Jundt G
Curr Top Pathol; 1989; 80():31-54. PubMed ID: 2776495
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of bone GLA protein in primary bone tumors.
Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
[TBL] [Abstract][Full Text] [Related]
35. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models.
Mayordomo E; Machado I; Giner F; Kresse SH; Myklebost O; Carda C; Navarro S; Llombart-Bosch A
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):453-61. PubMed ID: 20436344
[TBL] [Abstract][Full Text] [Related]
36. Electron microscopy of bone tumors--osteosarcoma, chondrosarcoma, giant cell tumor of bone.
Komiya S
Nihon Seikeigeka Gakkai Zasshi; 1982 Jul; 56(7):635-57. PubMed ID: 6960100
[TBL] [Abstract][Full Text] [Related]
37. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
38. Extraskeletal osteosarcoma.
Chung EB; Enzinger FM
Cancer; 1987 Sep; 60(5):1132-42. PubMed ID: 3475157
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
Chiba H; Matsuyama T
Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
[TBL] [Abstract][Full Text] [Related]
40. [The expression of noncollagenous proteins and the tumor differentiation in oral maxillofacial osteosarcoma].
Li J; He RG
Shanghai Kou Qiang Yi Xue; 2001 Mar; 10(1):39-42. PubMed ID: 14994076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
